Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

NCT06177522 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Neoadjuvant Therapy

Interventions

DRUG: Adebrelimab
DRUG: albumin-bound paclitaxel
DRUG: Gemcitabine

Sponsor

Jinling Hospital, China

Collaborators

[object Object]